Evaluation of the Anticancer Activity of Conessine against Human Melanoma (SK-MEL-28) Cells via Mitochondrial-Mediated Apoptotic Pathway

ABSTRACT

Background: Conessine is a steroidal alkaloid with diverse pharmacological activities, but its anticancer potential against melanoma and the mode of action remain poorly understood. Objectives: The present study evaluated the anticancer activity of conessine against human melanoma SK-MEL-28 cells and investigated its involvement in mitochondrial-mediated apoptosis. Materials and Methods: The cytotoxic effect of conessine was assessed using the MTT assay. Mitochondrial superoxide generation, membrane potential, induction of apoptosis, caspase-3 activity, and expression of apoptosis-related genes were examined using MitoSOX™ Red staining, flow cytometry, indirect ELISA, and real-time PCR, respectively. Results: Conessine significantly reduced SK-MEL-28 cell proliferation in a concentration-dependent manner (IC₅₀=76.78 µg/mL), whereas lower toxicity was observed in Human Dermal Fibroblast (HDF) cells (IC₅₀=143.33 µg/mL). Treatment with conessine enhanced the production of mitochondrial superoxide (76.78 µg/mL) and induced mitochondrial membrane depolarisation (54.50%). Conessine increased caspase-3 activity (1.7-fold increase), upregulated BAX expression, downregulated BCL2 expression, and enhanced the apoptotic cell populations (≥ 60%). Conclusion: These findings demonstrated that conessine exerts selective anticancer activity against SK-MEL-28 melanoma cells by inducing mitochondrial dysfunction and triggering the intrinsic apoptotic pathway. The study highlights conessine as a promising natural molecule for further development as a potential therapeutic agent against melanoma.

KEYWORDS

• Anti-apoptosis
• BAX
• BCL2
• Caspase-3
• Mitochondrial Apoptosis
• Reactive Oxygen Species

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20265707Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 60, ISSUE 4SFormulation and Evaluation of Liquisolid Tablet with Enhanced Dissolution of Ivacaftor by Using Box-Behnken DesignManisha Dnyanoba Chate, Swaroop Rameshwarji Lahoti · pp. s1405–s1415Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 4SDevelopment and Evaluation of Polymer-conjugated Solid Fast Dissolving Tablets of Ambroxol HydrochlorideVidhan Chand Bala, Mukesh Kumar Singh, Amit Kumar, Arvind Kumar Patel, Sunil Kumar Tiwari, Asheesh Kumar Gupta, Sushil Kumar · pp. s1416–s1429Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 4SQuality by Design Development of a Thermosensitive in situ Gel for Enhanced Ocular Delivery of CarvedilolAnurag Rajendra Panade, Sandip Akaram Bandgar, Riya Raghunath Patil, Indrayani Sandip Bandgar · pp. s1430–s1444Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 4SNovel Application of Mixed Solvency Concept for the Development of Topical Emulgel Formulations of Poorly Water-Soluble Drug, Piroxicam, and their EvaluationsJitendra Singh, Prateek Sahu, Sharad Prakash Pandey, Rajesh Kumar Maheshwari · pp. s1445–s1460Original ArticleSame type: Article